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Abstract: In this paper, records of all medical condi-
tions on death certificates are used to evaluate hyper-
tension-related mortality in North Carolina over the
decade 1968-1977. Use of both an inclusive hyperten-
sion recode category and multiple cause data resulted
in gains in information of over 750 per cent in all four
race/sex groups compared to the commonly used
underlying cause, hypertensive disease category.
Race, sex and age specific 10-year trends in death
rates for all mentions of hypertension are analyzed,
with comparisons to underlying cause mortality from
ischemit heart disease and stroke. Age-adjusted de-
clines of 19 to 24 per cent between 1968 and 1977 were
Introduction
Over the past decade, there has been a decline in cause
specific circulatory disease mortality rates-a phenomenon
that a recent National Institutes of Health conference'
concluded was real and not an artifact on the basis of a broad
variety of evidence. That investigation was conducted, how-
ever, without utilizing a potentially important source of
additional information available through the vital statistics
system on the status of circulatory disease mortality in the
United States population-the total occurrence of chronic
circulatory conditions on death certificates. The observation
of the decline in circulatory disease mortality was based on
the mortality rates for certain diseases only when those
diseases were identified as the "underlying" cause of death,
i.e., when the disease was determined to be the precipitating
factor in the chain of events that led to death. Such statistics
fail to utilize the considerable additional information on
conditions that frequently appear on death certificates as
other than the underlying cause. Some of these conditions,
such as hypertension, have major public health implications
in their own right in addition to their association with major
underlying causes of death.
The present study utilizes multiple cause of death data,
i.e., records of all medical conditions listed on death certifi-
cates, to monitor the total contribution of hypertension to
mortality in North Carolina over the period 1968 to 1977.
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observed for all race/sex groups, although non-White
declines occurred mainly at younger ages while White
declines (especially White males) occurred mainly at
older ages. The non-White excess of hypertension
mentions (compared to Whites) increased for males
and decreased for females. The decline in hyperten-
sion mentions, in spite of the increased awareness of
hypertension as a public health problem which would
make it more likely to be mentioned on death certifi-
cates, suggests that there was a real reduction in the
contribution of hypertension to total mortality over the
period. (Am J Public Health 1981 ;71:823-830.)
North Carolina is a particularly suitable region for study
since it is one of the few states for which multiple cause
mortality data are available for such a period of time; it
includes large numbers of non-Whites (mostly Afro-Ameri-
cans) who have notably different patterns of hypertension
than Whites; and it has been studied in the past with respect
to hypertension-related mortality.25 The decade 1968-1977
is a period for which mortality data were all coded under the
same revision of the International Classification of Diseases
(ICDA, 8th revision) and is of further interest because it is a
period during which underlying cause mortality from cardio-
vascular diseases has been declining nationally. " After
presentation of the multiple cause data on hypertension,
mortality rates for ischemic heart disease (IHD) and stroke
will be presented. These are the major underlying causes of
death that have received attention nationally, and it will be
of interest to see how the trends in their mortality rates
parallel the trends in the contribution of hypertension to total
mortality. Thus, the three goals of this paper are to: 1)
describe the additional information available on the role of
hypertension in mortality when all its mentions on death
certificates are considered, rather than only those which
appear as the underlying cause of death; 2) present temporal
trends in the age, race, and sex specific rates of the total
contribution of hypertension to death; and 3) compare the
trends in the mentions of hypertensive disease to underlying
cause mortality from IHD and stroke.
Materials and Methods
The total amount of information on hypertension avail-
able in mortality data is not often fully utilized for at least
two reasons.
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TABLE 1-Appearances of Selected Hypertension Categories on North Carolina Death Certifi-
cates by Race and Sex, 1975
Non-White White Non-White White
Males Males Females Females
Essential Hypertension (ICDA 401)
Total Mentions 368 639 381 634
Underlying Cause Occurrences 5 13 6 9
Ratio 73.6 49.2 63.5 70.4
Total Mentions of all Hypertension Codes 826 1336 891 1346
Underlying Cause Occurrences of Hypertensive Disease 96 122 102 112
Ratio 8.6 11.0 8.7 12.0
First, hypertension is represented in a complex way in
the ICDA, which makes it necessary to use a detailed
recoding procedure to include all codes indicating the pres-
ence of hypertension at death. While ICDA 400-404 is the
general category for hypertensive disease, the presence of
hypertension can also be indicated by a fourth digit level
code under IHD and stroke categories, including two codes
that were added after initial publication of the ICDA (412.1
and 412.2).9 Thus, in order to construct a rate that would
indicate the probability of death with mention of hyperten-
sion, any death certificate that listed hypertensive disease
(400-404) or any of the stroke and IHD codes that indicate
the presence of hypertension was included in the numerator
of the rate. Only one hypertension mention was counted per
death certificate.
The second and more important reason why much of the
information on hypertension is not utilized comes from the
practice of using mortality data where only the underlying
cause of death is reported. This failure to utilize information
on the other medical conditions on the death certificate is
largely due to the fact that the data released from vital
statistics agencies on individual deaths generally contain
only the underlying cause of death. However, the death
certificate permits the listing of multiple medical conditions
to more completely characterize the health state of the
decedent than is possible with a single condition. The death
certificate is organized so that certain types of temporal and
causative relations among medical conditions can be repre-
sented. Specifically, the death certificate form has two parts
on which medical conditions may be listed. Part I contains
three lines which indicate the temporal and causal sequence
of morbid events leading to death, and Part 2 indicates other
significant medical conditions contributing to death. For
underlying cause statistics, when more than a single disease
code appears on the death certificate, only one of these is
selected for presentation. While underlying cause statistics
may not greatly understate the presence at death of highly
lethal conditions, much information on common conditions
which are not often lethal conditions by themselves-such as
hypertension, diabetes or atherosclerosis-is lost. Examples
of the underreporting of hypertensive conditions in underly-
ing cause of death statistics are given in Table 1. Underre-
porting, indicated by the ratio of mentions to underlying
cause deaths, is most extreme in the case of essential benign
hypertension (ICDA 401) which in 1975 in North Carolina
was mentioned from 49.2 (White males) to 73.6 (non-White
males) times more often than it appeared as an underlying
cause of death. The magnitude of these ratios reflects both
the frequency of essential hypertension and the perception
that it is not a highly lethal condition by itself. Thus
underreporting in the underlying cause of death mortality
statistics is severe. The lethal disease categories have ratios
which are closer to unity, meaning that if they are mentioned
on the death certificate, they are more likely to be chosen as
the underlying cause of death.
A general indication of the increase in information
gained in this study from using both an inclusive "all
hypertension" category and multiple cause of death data is
reflected in the ratios of all mentions of hypertension to
underlying cause deaths from hypertensive disease, which in
1975 were 8.6, 11.0, 8.7, and 12.0 for non-White males,
White males, non-White females, and White females respec-
tively (Table 1). Thus, the gains in information on hyperten-
sion were relatively greater for Whites, although increases
were over 750 per cent for all race/sex groups. The logic of
the relationship between the absolute level of the rates and
the ratio of total mentions to underlying cause occurrences
suggests that the ratio may be interpreted as indicating the
differential severity of the disease for different demographic
groups. For example, the ratio of the total number of
mentions of hypertension to its mention only as the underly-
ing cause is greater for Whites, even though the absolute
total mention rates are lower for Whites. Not only do Whites
experience less hypertension, but it is less lethal for them.
For non-Whites, hypertension is not only more prevalent,
but it appears more often as the underlying cause of death
because the physician filling out the certificate considered
the general condition more important in causing death than
some site-specific failure such as stroke or IHD. (There are
so few underlying cause deaths attributed to essential hyper-
tension that it is difficult to interpret race/sex differences in
the ratio for that entity.)
In discussing the total mentions of hypertension on
death certificates, it is important to introduce the concept of
"prevalence at death" because of its sometimes confusing
use in previous studies of multiple cause data. For example,
Markush and Seigel'° measured prevalence at death by
surveying certifiers of deaths to find if conditions of interest
were present in the last year of life. "Prevalence at death" in
their case was reported as a proportion of total deaths.
Heyman, et al,2 however, used the term "prevalence at
death" to refer to the death rate for all mentions of a
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FIGURE 1-Death Rate for All Death Certificate Mentions of Hyper-
tension, North Carolina, 1968 to 1977, for Ages 40 to 44
condition, using populations in the denominators rather than
total deaths. Although the rates calculated in this study are
similar to those employed by Heyman, et al, the "preva-
lence at death" terminology has not been used because it
seems to be more appropriately applied as a measure of
prevalence among deaths, as employed by Markush and
Seigel,'0 than as an index of the rate of association of the
diseases with death.
Death rates were constructed based on all deaths where
hypertension was mentioned, as well as for IHD and stroke
as underlying causes of death, for the ten-year period 1968 to
1977, for five-year age groups from 40-44 to 85+, by race
and sex. The 1968 and 1969 mortality data were abstracted
from the National Center for Health Statistics national
multiple cause mortality files. Mortality data for 1970-71 and
1973-77 were available from the North Carolina Division of
Vital Statistics. All US mortality data for the year 1972,
however, are only available as a 50 per cent sample, taken
with unknown sampling method and therefore unknown
bias, especially at the state level. It was therefore decided to
treat the data points for 1972 as missing and to replace them
with the average of the rates for 1971 and 1973. This was
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FIGURE 2-Death Rate for All Death Certificate Mentions of Hyper-
tension, North Carolina, 1968 to 1977, ages 75 to 79
values for that year post hoc on the basis of data for other
years. Denominators for each year from 1970 to 1977 were
derived from population estimates made for the National
Cancer Institute by the Bureau of the Census (Richard Irwin,
Population Division, US Bureau of the Census). Denomina-
tors for the years 1968 and 1969 were derived from popula-
tion estimates provided by the US Environmental Protection
Agency (John Van Bruggen). Age-adjusted total rates were




Table 2 gives the age-specific and age-adjusted rates of
death with mention of hypertension (per 100,000) for the first
and last years of the time series. Figures 1 and 2 show the
trend across the ten-year period for two age groups, 40-44
and 75-79. An examination of these data helps to establish
both the absolute level of the rate of occurrence of hyperten-
sion mentions and the differences between race/sex groups.
Clearly manifest are the large absolute declines experienced
by non-Whites over the ten-year period. For example, the
Table 2-Age-Specific and Age-Adjusted Death Rate (per 100,000) for All Mentions of Hypertension by Race and Sex, and Percent
Change, 198 and 1977
Non-White Males White Males Non-White Females White Females
Age (yrs) 1968 1977 % Change 1968 1977 % Change 1968 1977 % Change 1968 1977 % Change
40-44 152.8 85.7 - 43.9 16.2 18.3 13.0 149.9 80.3 - 46.4 7.4 3.4 - 54.1
45-49 263.2 127.5 - 51.6 41.5 34.7 - 16.4 230.7 102.8 - 55.4 26.0 14.2 - 45.4
50-54 332.1 260.5 - 21.6 89.6 71.4 - 20.3 317.5 192.9 - 39.2 48.7 25.4 - 47.8
55-59 582.6 426.1 - 26.9 159.4 134.5 - 15.6 360.6 286.9 - 20.4 70.1 64.6 - 7.8
60-64 755.9 572.5 - 24.3 236.0 202.0 - 14.4 669.4 531.0 - 20.7 115.6 111.2 - 3.8
65-69 859.0 777.4 - 9.5 416.7 291.8 - 30.0 1012.9 613.1 - 39.5 210.8 190.7 - 9.5
70-74 988.7 1030.2 + 4.2 592.6 451.0 - 23.9 1167.7 883.2 - 24.4 421.1 303.4 - 30.0
75-79 1353.6 1404.4 + 3.8 812.0 635.3 - 21.8 1450.7 1420.3 - 2.1 662.6 561.5 - 15.3
80-84 1767.5 1238.1 - 30.0 1230.6 826.7 - 32.8 1246.2 1168.0 - 6.3 1089.7 864.7 - 20.6
85+ 1261.8 1046.5 - 17.1 1353.0 1084.6 - 19.8 1757.7 1491.9 - 15.1 1526.5 1257.2 - 17.6
Age-
Adjusted 558.2 449.7 - 19.4 237.0 183.5 - 22.6 515.0 391.0 - 24.1 162.7 131.4 - 19.2















TABLE 3-Ratios of Non-White to White Age-Specific and Age-Adjusted Death Rates for All
Mentions of Hypertension by Sex, and Per Cent Change, 1968 and 1977
Males Females
Age (yrs) 1968 1977 % Change 1968 1977 % Change
40-44 9.4 4.7 -50.0 20.3 23.6 + 16.9
45-49 6.3 3.7 -41.3 8.9 7.2 -19.1
50-54 3.7 3.6 -2.7 6.5 7.6 + 16.9
55-59 3.7 3.2 -13.5 5.1 4.4 -13.7
60-64 3.2 2.8 -12.5 5.8 4.7 -19.0
65-69 2.1 2.7 +28.6 4.8 3.2 -33.3
70-74 1.7 2.3 + 35.3 2.8 2.9 + 3.6
75-79 1.7 2.2 + 29.4 2.2 2.5 +13.6
80-84 1.4 1.5 +7.1 1.1 1.4 +27.3
85+ 0.9 1.0 +11.1 1.2 1.2 0.0
TOTAL 2.4 2.5 +4.2 3.2 3.0 -6.3
rate of hypertension mentions for non-White males aged 40-
44 dropped from 152.8 to 85.7 per 100,000 and for non-White
females from 149.9 to 80.3 per 100,000 between 1968 and
1977.
The overall declines in the rates of hypertension men-
tions for the four race/sex groups are represented by the per
cent change in the age-adjusted rate between 1968 and 1977:
19.4 per cent for non-White males, 22.6 per cent for White
males, 24.1 per cent for non-White females, and 19.2 per
cent for White females. While the groups experienced simi-
lar percentage declines in the total rates, there were consid-
erable differences in the age pattern of these declines for the
various race/sex groups.
Non-White males experienced their largest declines at
the youngest ages, 43.9 per cent at ages 40-44 and 51.6 per
cent at ages 45-49. From ages 50-69, declines were generally
smaller, with actual increases occurring at ages 70-79.
Modest declines were again registered in the oldest age
categories. This pattern is in marked contrast to the White
male experience. At ages 64 and below, White male declines
were much less than for non-White males, with the largest
White male decline being less than the smallest non-White
male decline and with an increase of 13 per cent observed for
the youngest age group. The greatest declines for White
males, of approximately 20 to 30 per cent, occurred at ages
65+. Thus, the largest declines for non-White males oc-
curred at younger ages, while for White males they occurred
at older ages (Table 2, Figure 1).
Non-White females experienced the largest total decline
of any race/sex group, 24.1 per cent. The age distribution of
their decline was similar to the non-White male pattern, but
non-White females manifested declines at ages where non-
White males experienced increases (i.e., ages 70-79). Non-
White female declines were very large at ages 40-49, being
on the order of 50 per cent. Substantial declines were also
manifest at ages 50-74, with small declines at ages 75+.
Although White females showed the smallest age-adjusted
per cent change of all race/sex groups, they did manifest
declines at all ages, with especially large declines below age
55. Declines were small (under 10 per cent) at ages 55-69,
and modest at 70+.
The striking differences between the White and non-
White rates evident in Figures 1 and 2 and in Table 2 are
summarized in Table 3, which presents the ratios of non-
White to White death rates for all mentions of hypertension.
These ratios are largest for females, and at younger ages.
The ratios decrease steadily with age. In 1968, non-White
male rates of hypertension mentions were 9.4 times the
White male rates at ages 40-44. The 1968 ratio is smaller at
older ages, being only 1.7 at ages 75-79 and less than 1.0 at
ages 85+. For females, the non-White/White ratios were
even larger, from 20.3 at ages 40-44 to 2.2 at ages 75-79, with
no ratios less than 1.0 even at the most advanced ages. The
age-specific per cent changes in the ratios between 1968 and
1977 are also given in Table 3. For example, at ages 40-44,
since non-White male rates decreased and White male rates
increased, there was a 50 per cent reduction in the male ratio
between 1968 and 1977. Table 3 shows that the non-White/
White male ratios decreased between 1968 and 1977 below
age 65, but increased at older ages, resulting in a 4.2 per cent
increase (from 2.4 to 2.5) in the total age-adjusted ratio
between the two years. The age pattern offemale ratios was
more uneven, with increases at ages 40-44, 50-54, and above
age 70. Overall, however, the female ratio declined 6.3 per
cent between 1968 and 1977, from 3.2 to 3.0. Thus, while
non-White males lost ground relative to White males, non-
White females improved relative to White females.
IHD and Stroke
Hypertension is a condition that is considered to be a
common precursor of both IHD and stroke. However, while
hypertension is often viewed as a circulatory disease risk
factor, IHD and stroke are site-specific and often acute
manifestations of underlying processes such as hypertension
and atherosclerosis. Thus, secular trends in the contribution
of hypertension to mortality are important not only for
understanding hypertension as a disease entity itself, but for
their implications for underlying cause mortality from IHD
and stroke. Furthermore, these are the major entities which
have been used to describe the decline of US circulatory
disease mortality. Thus, data for temporal trends in the
underlying cause mortality rates for IHD and stroke will be
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FIGURE 3-Death Rate for Ischemic Heart Disease, North Carolina,
1968 to 1977, for Ages 40 to 44
presented so that their similarities to and differences from
the trends for hypertension mentions can be evaluated.
Table 4 gives the age-specific and age-adjusted death
rates for IHD by race/sex for the first and last years of the
time series. Underlying cause death rates for IHD, the
leading cause of death in the US, are higher than rates of
hypertension mentions for all age and race/sex groups except
for non-White females at the youngest ages. In Figures 3 and
4, which show the time trends in IHD death rates for age
groups 40-44 and 75-79, it can be seen that there is a greater
similarity in the absolute levels of the rates by sex than by
race, with females having lower rates than males. For IHD,
while Whites, and especially White females, are advantaged
with respect to non-Whites at younger ages (Figure 2), non-
Whites tend to be advantaged at older ages. At ages 75-79
(Figure 4), non-White males are advantaged for nine of the
ten years, and non-White females for two of the ten. By ages
85 +, non-Whites are advantaged in all years for both sexes.
Absolute levels of rates of stroke as an underlying cause
of death are more similar to mentions of hypertension than
IHD rates, generally being slightly lower at the younger ages
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FIGURE 4-Death Rate for Ischemic Heart Disease, North Carolina,
1968 to 1977, for Ages 75 to 79
striking non-White disadvantage seen for hypertension is
evident, although the relative differences are not quite so
large for stroke. In Figure 5, which shows the ten years of
rates for stroke at ages 40-44, the race difference in stroke
mortality at these ages is evident, as are the very large
declines in absolute levels of stroke mortality for non-
Whites. At older ages, however, there is substantial conver-
gence between the races in stroke rates. At ages 80 and
above, non-White stroke rates are actually less than White
rates in both 1968 and 1977 (Table 5), and by ages 85 +, this
is true for all ten years. Thus, for all three diseases, non-
Whites are disadvantaged with respect to Whites at younger
ages. This relative disadvantage tends to be reversed for
IHD and stroke by ages 80-84 (male IHD rates tend to
converge at about ages 60-64), but for hypertension is
manifest at all ages.
Total age-adjusted declines in IHD were less than
hypertension declines for all race/sex groups (Table 4). Also,
the sex difference evident in the absolute levels of the rates
in 1968 increased over the ten-year period; males, who had
higher rates in 1968, also experienced less decline up to 1977,
increasing the sex difference in IHD mortality. Female
TABLE 4-Age-Specific and Age-Adjusted Death Rate (per 100,000) for Ischemic Heart Disease by Race and Sex, and Per Cent
Change, 1968 and 1977
Non-white Males White Males Non-white Females White Females
Age (yrs) 1968 1977 % Change 1968 1977 % Change 1968 1977 % Change 1968 1977 % Change
40-44 246.0 179.3 - 27.1 153.8 127.0 - 17.4 152.9 61.0 - 60.1 21.4 16.8 - 21.5
45-49 394.8 288.7 -26.9 312.5 239.5 -23.4 191.7 83.5 -56.4 41.1 36.7 -10.7
50-54 590.4 460.5 -22.0 521.6 457.4 -12.3 303.0 205.7 -32.1 111.4 81.9 -26.5
55-59 1004.7 760.4 -24.3 905.8 782.7 -13.6 468.8 358.6 -23.5 176.7 158.5 -10.3
60-64 1204.7 1308.6 + 8.6 1217.6 1165.5 -4.3 799.4 551.9 -31.0 336.1 307.8 - 8.4
65-69 1816.6 1593.7 -12.3 1824.5 1696.7 -7.0 1359.7 827.2 -39.2 689.3 507.4 -26.4
70-74 2702.4 2338.1 -13.5 2676.3 2430.3 -9.2 1824.1 1440.2 - 21.0 1245.6 939.6 - 24.6
75-79 3263.5 3566.4 +9.3 3714.0 3227.3 -13.1 2450.7 2884.3 + 17.7 2230.4 1837.8 -17.6
80-84 3637.0 4152.7 +14.2 5638.2 4856.9 -13.9 3207.9 2398.4 - 25.2 4046.9 3104.9 - 23.3
85 + 4574.1 4534.9 -0.9 9320.5 7624.9 -18.2 3899.0 4353.2 + 11.6 6710.6 5957.9 - 11.2
Age-
Adjusted 1128.3 1037.4 - 8.1 1216.1 1071.3 -11.9 755.0 592.7 - 21.5 536.8 436.2 -18.7








r) WIIITF MMF. -
El WHITF FFMALES O.,..
-WHIrF w ".)o NON C>




















a:~ A MON-WlITE MALES
CL X NON-WHITE FFMRLES
1968 1969 1970 1971 1972 1973 1974 1975 1976 1977
YEAR
FIGURE 5-Death Rate for Stroke, North Carolina, 1968 to 1977, for
Ages 40 to 44
declines were about twice the male declines, about 21.5 per
cent for non-White females and 18.7 per cent for White
females, compared to 8.1 and 11.9 per cent for non-White
and White males.
As was observed for hypertension, there were major
differences in the age-specific declines between race/sex
groups. Non-white declines in IHD, like their declines in
hypertension, were concentrated in the younger ages, with
non-white females experiencing the largest age-specific de-
cline for any of the three diseases, 60.1 per cent at age 40-44.
Very large declines of greater than 50 per cent below age 50
were accompanied by declines of about 20 to 30 per cent at
other ages with the exceptions of ages 75-79 and 85 +, which
showed increases. Non-White males also showed increases
in some age groups (60-64 and 75-84), with declines of 20 to
30 per cent occurring below age 60. Whites of both sexes
showed small to moderate declines at all ages.
Total age-adjusted declines for stroke as the underlying
cause of death (Table 5) were greater than declines for IHD
for all race/sex groups, a finding in agreement with historical
trends for the two diseases in the US." Total stroke de-
clines, which were similar across race/sex groups, were also
greater than declines in mentions of hypertension. Although
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FIGURE 6-Death Rate for Stroke, North Carolina, 1968 to 1977, for
Ages 75 to 79
stroke than females, 33.2 and 32.6 per cent for White and
non-White males, compared to 31.3 per cent for both female
groups. Non-White males experienced declines of over 30
per cent in all age groups below age 75, with a 42.5 per cent
decline at ages 70-74, an age group that showed a 4.2 per
cent increase in hypertension mentions. Non-White males
showed the only age-specific increase in stroke mortality,
2.9 per cent at ages 85 +. White male declines were fairly
consistent over the age groups, with only ages 40-49 and 60-
64 showing declines of under 30 per cent. Non-White fe-
males showed an age pattern of stroke declines more consis-
tent with those for hypertension and IHD, with largest
declines below age 60, moderate declines at 60-74, and
smaller declines at the oldest ages. White females experi-
enced their largest decline, almost 50 per cent, at ages 40-44,
with their smallest declines, as for the other diseases,
occurring between ages 50 and 64.
While the age pattern of proportional declines for IHD
and stroke for the various demographic groups shows some
parallels to the age pattern of declines for hypertension
mentions, these parallels are not exact, suggesting that each
of the three disease states, although interrelated, is apparent-
ly subject in different ways to the mechanisms reducing
circulatory disease mortality.
TABLE 5-Age-Specific and Age-Adjusted Death Rate (per 100,000) for Stroke by Race and Sex, and Per Cent Change, 1968 and 1977
Non-White Males White Males Non-White Females White Females
Age (yrs) 1968 1977 % Change 1968 1977 $ Change 1968 1977 % Change 1968 1977 % Change
40-44 152.8 70.2 -54.1 24.8 17.4 -29.8 82.6 48.2 -41.6 21.4 10.9 -49.1
45-49 165.5 112.5 -32.0 44.1 38.2 -13.4 136.5 61.0 -55.3 31.0 17.5 -43.5
50-54 278.8 181.2 -35.0 67.5 40.1 -40.6 169.5 118.9 -29.9 37.5 30.3 -19.2
55-59 417.5 275.7 -34.0 117.2 78.4 -33.1 284.5 136.3 -52.1 60.7 54.0 -11.0
60-64 714.6 383.4 -46.3 199.8 148.2 -25.8 419.0 259.2 -38.1 139.7 107.1 -23.3
65-69 929.4 588.6 -36.7 459.5 278.6 -39.4 649.6 415.7 -36.0 255.7 169.9 -33.6
70-74 1230.4 707.7 -42.5 832.4 518.9 -37.7 1159.2 733.7 -36.7 594.3 331.4 -44.2
75-79 1613.2 1230.9 -23.7 1517.2 1023.7 -33.5 1732.4 1485.9 -14.2 1150.9 801.2 -30.4
80-84 1631.5 1573.4 -3.6 2525.5 1756.8 -30.4 1684.7 1370.5 -18.7 2145.8 1516.4 -29.3
85 + 2260.8 2325.6 + 2.9 4945.9 3330.4 -32.7 2492.8 2186.8 -12.3 4401.4 3129.2 -28.9
Age-
Adjusted 550.8 371.3 -32.6 363.1 242.7 -33.2 443.4 304.8 -31.3 272.8 187.3 -31.3
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Discussion
The three main goals of this study of the use of multiple
cause mortality data to describe circulatory disease mortal-
ity declines can now be integrated into a more unified
picture. The multiple cause information on all mentions of
hypertension is important because, by scanning all medical
conditions listed on death certificates and counting all occur-
rences of hypertension, it is possible to monitor the total
contribution of hypertension to mortality. This procedure
produces more information than is available in studies
restricted to the occurrence of hypertensive diseases as an
underlying cause of death. Additionally, by using a broadly
defined disease category, the reliability (i.e., consistency of
diagnosis across time and place) of the observation of a
hypertension occurrence is increased, at least when com-
pared to highly specific disease classifications.'2
An examination of the trends in the rate of occurrence
of hypertension on death certificates produced insight into a
variety of issues. For example, the trends for all race/sex
groups indicated substantial declines in the frequency of
mentions of hypertension on death certificates in North
Carolina over the period 1968-1977. This was a time of
increased awareness, especially in the medical community,
that hypertension was an important health risk. Thus, other
things being equal, it is expected that physicians and medical
examiners would be more likely to suspect or detect hyper-
tension and list it as an associated condition on the death
certificate. The fact that declines were registered in spite of
this increased awareness suggests that there was a real
reduction in the contribution of hypertension to total mortal-
ity during the period.
The age-specific pattern of declines in the rate of
hypertension mentions for the various demographic groups
also provided insight into factors that might have contributed
to the observed trends. For example, the NIH conference on
the decline of circulatory disease mortality' considered the
role of the medical management of hypertension in trends in
heart disease mortality. If medical management has been the
major factor in the decline of hypertension mentions it would
be expected that groups which are most likely to receive
medical care and follow treatment regimens would show the
largest declines. Data presented here, however, show that
the largest declines in hypertension mentions occurred for
non-Whites at the youngest ages-groups that probably
receive less medical attention than Whites, given well known
racial and socioeconomic differentials in the use of and
access to medical care. For example, in a recent survey of a
rural North Carolina community the prevalence of hyperten-
sion among untreated individuals was consistently higher for
Blacks than Whites, with only 19 per cent of Black males
under 50 treated and under control.'3 Still their declines far
exceeded those of young White males. It may be significant
that young non-Whites have been experiencing educational
and occupational advancements.
The rate of change in mentions of hypertension more
nearly paralleled that of stroke mortality than IHD. This
finding is in agreement with epidemiologic studies which
show that hypertension is a stronger risk factor for stroke
than for IHD. Only non-White females showed an age-
specific change in IHD that closely paralleled the trends for
hypertension mentions. The interaction between hyperten-
sion and other risk factors is probably different in different
populations, and it may be that non-White females respond-
ed more favorably to reductions in blood pressure (in terms
of lower IHD mortality) than other groups. In fact, the
fraction of excess deaths associated with hypertension in
Evans County, Georgia was shown to be far greater for
Black females than for other groups.'4 In this study, non-
White females showed the largest total age-adjusted decline
of all race/sex groups for both hypertension and IHD.
This study has presented multiple cause information on
the total mention of hypertension on North Carolina death
certificates over the period 1968-1977. It is difficult to
measure hypertension for the total living population, so the
utilization of multiple cause of death statistics for the moni-
toring of the condition in mortality data at the population
level takes on special importance. In combination with
future multiple cause studies of other chronic degenerative
conditions, it may be possible to delineate important pat-
terns in the relation of physiological conditions reported at
death to mortality from various major diseases over time,
and by race, sex, and region.
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I Conference on Human Functioning Scheduled for September I
TITLE: Fifth International Conference on Human Functioning
WHERE: Century II Convention Center, Wichita, Kansas
WHEN: September 17-20, 1981
GOAL: To explore what can be learned from a Synergetic input from an international faculty of health
professionals, who are on the leading edge of their fields, dealing with issues of medical care
and health dilemmas that face us in preparing for the 21st Century.
ACCREDITATION: 22 Category I credits for physicians
22 CE contact hours for health-related professionals
SPONSOR: BioMedical Synergistics Institute (BSI)
(a non-profit educational organization)
CO-SPONSORS: University of Kansas School of Medicine-Wichita
Center for Continuing Health Education, Wichita State University
FEES: $200 for physicians in health professions
$100 for health-related professionals and other enrollees
$25 for full-time students
For more information write or call: Betty Richards, BSI, 434 N. Oliver, Wichita, KS 67208, 316/686-
1031.
Symposium Scheduled on Diet and Exercise
A symposium on "Diet and Exercise: Synergism in Health Maintenance" will be held on
November 3-4, in Lake Buena Vista, FL (Walt Disney World Complex). The Symposium will be
sponsored by the Department of Foods and Nutrition, American Medical Association, in conjunction
with the AMA's Council on Scientific Affairs and Council on Continuing Physician Education, and the
Florida Medical Association.
The Symposium will focus on the role of nutrition and exercise in the promotion of health and the
treatment of major health problems. Emphasis will be on the physiologic effects of moderate habitual
activity coupled with sound nutrition practices, i.e., the role of nutrition and exercise in health
maintenance and in the treatment of some of our chronic degenerative disease states.
The registration fee for the two-day symposium is $60 (includes luncheon on both days). The
American Medical Association Council on Continuing Physician Education has designated this activity
as meeting the criteria for Category I credit on an hour-for-hour basis towards the Physician's
Recognition Award of the AMA. Additionally, the American Dietetic Association has approved
thirteen (13) continuing education hours for registered dietitians attending the Symposium.
For further information, contact: Department of Foods and Nutrition, American Medical Associa-
tion, 535 N. Dearborn St., Chicago, IL 60610, tel: 312/751-6524.
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